Xencor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.About XNCR
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.
XNCR Key Statistics
Stock Snapshot
The current Xencor(XNCR) stock price is $25.55, with a market capitalization of 1.87B. The stock trades at a price-to-earnings (P/E) ratio of -11.60.
On 2026-10-23, Xencor(XNCR) stock traded between a low of $24.42 and a high of $25.81. Shares are currently priced at $25.55, which is +4.6% above the low and -1.0% below the high.
Xencor(XNCR) shares are trading with a volume of 1.46M, against a daily average of 1.32M.
During the past year, Xencor(XNCR) stock moved between $10.38 at its lowest and $30.61 at its peak.
During the past year, Xencor(XNCR) stock moved between $10.38 at its lowest and $30.61 at its peak.
XNCR News
Xencor (XNCR) is moving back into focus after the company set an October 26 webcast to walk investors through Phase 1 data for its XmAb819 kidney cancer program...
Xencor recently reported that Phase 1 results for its XmAb819 bispecific antibody in advanced clear cell renal cell carcinoma were shared at ESMO 2026 and discu...
Xencor (XNCR) to discuss results from the Phase 1 Study of XmAb819, an ENPP3 x CD3 T-cell engaging bispecific antibody, in development for patients with advance...
Analyst ratings
79%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.